- Report
- August 2025
- 188 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- June 2025
- 150 Pages
Global
From €3362EUR$3,850USD£2,921GBP
€4236EUR$4,850USD£3,680GBP
- Report
- September 2025
- 478 Pages
Global
From €5109EUR$5,850USD£4,438GBP
- Report
- March 2025
- 224 Pages
Global
From €3886EUR$4,450USD£3,376GBP
- Training
- February 2026
- 1 Day
Global
€773EUR$916USD£649GBP
€892EUR$1,058USD£749GBP
- Training
- March 2026
- 2 Days
Europe
€1548EUR$1,834USD£1,299GBP
€1786EUR$2,117USD£1,499GBP
- Training
- October 2025
- 3 Days
Asia Pacific
€2262EUR$2,681USD£1,899GBP
- Report
- March 2024
- 78 Pages
Global
From €4323EUR$4,950USD£3,755GBP
- Report
- August 2024
- 135 Pages
Global
From €2619EUR$2,999USD£2,275GBP
- Report
- August 2022
- 30 Pages
Global
From €2838EUR$3,250USD£2,466GBP
- Report
- August 2022
- 110 Pages
Global
From €1747EUR$2,000USD£1,517GBP
- Report
- July 2022
- 71 Pages
Global
From €1747EUR$2,000USD£1,517GBP
- Report
- July 2022
- 57 Pages
Global
From €1747EUR$2,000USD£1,517GBP
- Report
- June 2022
- 93 Pages
Global
From €1747EUR$2,000USD£1,517GBP
- Training
- October 2021
- 1 Day
Latin America
From €1134EUR$1,299USD£986GBP
- Report
- February 2018
- 135 Pages
Global
From €4367EUR$5,000USD£3,793GBP
- Training
- 7 Hours
Global
- Training
- 4 Hours
Europe
- Training
- 90 Minutes
Europe
- Report
- December 2022
- 94 Pages
Global
From €1747EUR$2,000USD£1,517GBP

The Marketing Authorization market is a key component of the Drug Discovery process. It is the process of obtaining approval from regulatory authorities to market a drug or medical device. This process involves submitting a dossier of data to the relevant regulatory body, which is then reviewed to ensure the product meets safety and efficacy standards. The dossier includes pre-clinical and clinical data, manufacturing information, and other relevant information. The process also includes post-marketing surveillance to ensure the product continues to meet safety and efficacy standards.
Companies in the Marketing Authorization market include AbbVie, AstraZeneca, Bayer, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more